Teva Pharmaceutical Industries has agreed to buy Allergan Plc's generic drugs business for $40.5 billion in a cash and stock deal that will turn the Israeli company into one of the world's largest pharmaceutical firms.
Teva Pharmaceutical Industries
Breaking News
Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.
The single largest stock holding of Soros Fund Management in the fourth quarter is Israeli drugmaker Teva Pharmaceutical Industries Ltd, Reuters reported citing a February 14 filing with the US Securities and Exchange Commission.
The world's largest generic drugmaker, Teva Pharmaceutical Industries Ltd, has chosen Erez Vigodman to become its President and Chief Executive Officer beginning February 11, Bloomberg reported.
TheMarker, a financial news website, said generic drugmaker Teva Pharmaceutical Industries is set to name Erez Vigodman as its new Chief Executive on January 13 at the JPMorgan Healthcare Conference in San Francisco, Reuters reported.
CEO Jeremy Levin resigns from Teva, but board is confident they will find a permanent replacement.
Subscribe to VCpost newsletter
Most Popular
- China Hits 2 U.S. Defense Companies With Sanctions For Selling Military Weapons to Taiwan
- 940,000 Taxpayers May Receive Extra $932 Tax Refunds From IRS; Here's Why!
- American Airlines Pilots Union Issues Urgent Safety Alert Over Maintenance Issues
- Innocent Female Uber Driver, 61, Shot Dead by 81-Year-Old Ohio Man Who Was Targeted by Scammers
- Google Starts Removing Links to California News Websites in Response to Journalism Preservation Act
- Customers Rush into 99 Cents Only Stores in California Ahead of Closures
- Donald Trump Urges His Followers to Support Truth Social as Its Parent Company’s Stock Continues to Dive
- Spirit Airlines Staff at Florida Airport Filmed Cursing a 'Karen' Passenger After Moaning About Her Flight
